Breaking News, Financial News

Financial Report: WuXi PharmaTech

Manufacturing revenue up 33% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi PharmaTech
 
4Q Revenues: $190.6 million (+21%)

4Q Earnings: $33 million (flat)

FY Revenues: $674.3 million (+17%)

FY Earnings: $112.2 million (-2%)

Comments: Lab Services Revenue grew 18% to $140.5 million in the quarter. Manufacturing Services Revenue increased 33% to $50.1 million. For the year, Lab Services Revenue was $492.0 million, up 14%, and Manufacturing Services Revenue increased 24% to $182.3 million.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters